Published in Free Radic Biol Med on January 01, 1992
The role of Nrf2-mediated pathway in cardiac remodeling and heart failure. Oxid Med Cell Longev (2014) 0.90
Water-soluble acacetin prodrug confers significant cardioprotection against ischemia/reperfusion injury. Sci Rep (2016) 0.75
Nitric oxide homeostasis as a target for drug additives to cardioplegia. Br J Pharmacol (2007) 0.75
Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J (2005) 5.40
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am Coll Cardiol (1995) 4.50
Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med (1992) 3.87
Human copper-containing superoxide dismutase of high molecular weight. Proc Natl Acad Sci U S A (1982) 3.45
[Acute coronary syndromes. Simplified routines with early exercise test performed at the intensive coronary care units]. Lakartidningen (1993) 3.19
Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group. Circulation (1999) 3.06
Mice lacking extracellular superoxide dismutase are more sensitive to hyperoxia. Proc Natl Acad Sci U S A (1995) 2.84
Newly detected abnormal glucose tolerance: an important predictor of long-term outcome after myocardial infarction. Eur Heart J (2004) 2.80
Extracellular superoxide dismutase and other superoxide dismutase isoenzymes in tissues from nine mammalian species. Biochem J (1984) 2.74
Extracellular superoxide dismutase in human tissues and human cell lines. J Clin Invest (1984) 2.39
Superoxide dismutase in extracellular fluids. Clin Chim Acta (1982) 2.32
A comparison of the acute and long-term hemodynamic effects of ventricular inhibited and atrial synchronous ventricular inhibited pacing. Circulation (1982) 2.22
Isolation and sequence of complementary DNA encoding human extracellular superoxide dismutase. Proc Natl Acad Sci U S A (1987) 2.20
Copper- and zinc-containing superoxide dismutase, manganese-containing superoxide dismutase, catalase, and glutathione peroxidase in normal and neoplastic human cell lines and normal human tissues. Cancer Res (1982) 2.19
Lipoprotein(a) as a determinant of coronary heart disease in young women. Circulation (1997) 2.13
The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor. Ann Oncol (2012) 2.02
Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Eur J Surg Oncol (2013) 1.99
CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J (1981) 1.91
Properties of extracellular superoxide dismutase from human lung. Biochem J (1984) 1.88
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI Study Group. Diabetes Insulin-Glucose in Acute Myocardial Infarction. Eur Heart J (1996) 1.83
Heparin-induced release of extracellular superoxide dismutase to human blood plasma. Biochem J (1987) 1.76
Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J (1997) 1.76
Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients. Diabetes Care (1999) 1.72
Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat Genet (1995) 1.70
Immunocytochemical localization of extracellular superoxide dismutase in human lung. Lab Invest (1994) 1.62
Cost-effectiveness of intense insulin treatment after acute myocardial infarction in patients with diabetes mellitus; results from the DIGAMI study. Eur Heart J (2000) 1.60
Phenotypic heterogeneity in motor neuron disease patients with CuZn-superoxide dismutase mutations in Scandinavia. Brain (1997) 1.55
The heparin-binding domain of extracellular superoxide dismutase C and formation of variants with reduced heparin affinity. J Biol Chem (1992) 1.55
Difference in mortality between patients treated with captopril or enalapril in the Xamoterol in Severe Heart Failure Study. Am J Cardiol (1991) 1.52
10-fold increase in human plasma extracellular superoxide dismutase content caused by a mutation in heparin-binding domain. J Biol Chem (1994) 1.49
The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol (1995) 1.49
Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves. J Am Coll Cardiol (1994) 1.46
Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ (1994) 1.46
Social relations and extent and severity of coronary artery disease. The Stockholm Female Coronary Risk Study. Eur Heart J (1998) 1.45
Continuous ambulatory haemodynamic monitoring with an implantable system. The feasibility of a new technique. Eur Heart J (1998) 1.44
Beta cell dysfunction in patients with acute myocardial infarction but without previously known type 2 diabetes: a report from the GAMI study. Diabetologia (2005) 1.44
Expression of human extracellular superoxide dismutase in Chinese hamster ovary cells and characterization of the product. Proc Natl Acad Sci U S A (1987) 1.43
Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure. Eur Heart J (2002) 1.42
Extracellular superoxide dismutase in the vascular system of mammals. Biochem J (1988) 1.41
Phenformin and pulmonary hypertension. Br Heart J (1973) 1.40
A new apparatus for detection of impending pacemaker failure in patients treated with implanted pacemakers. Cardiovasc Res (1970) 1.39
Superoxide dismutase isoenzymes in the human eye. Invest Ophthalmol Vis Sci (1998) 1.37
Preparation and properties of the major copper-binding component in human fetal liver. Its identification as metallothionein. J Biol Chem (1978) 1.37
Monitoring of mixed venous oxygen saturation and pressure from biosensors in the right ventricle. A 24 hour study in patients with heart failure. Eur Heart J (1995) 1.37
Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase). Biochemistry (1976) 1.36
Cyclin D1 overexpression is a negative predictive factor for tamoxifen response in postmenopausal breast cancer patients. Br J Cancer (2004) 1.36
Superoxide dismutase isoenzymes of the synovial fluid in rheumatoid arthritis and in reactive arthritides. Ann Rheum Dis (1986) 1.35
A rapid and specific method for isolation of thiol-containing peptides from large proteins by thiol-disulfide exchange on a solid support. Proc Natl Acad Sci U S A (1975) 1.33
Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. Eur Heart J (2000) 1.31
Re-used pacemakers--as safe as new? A retrospective case-control study. Eur Heart J (1998) 1.31
Myocardial infarction in patients with diabetes mellitus. Eur Heart J (1988) 1.30
Two-year results of a controlled study of residential rehabilitation for patients treated with percutaneous transluminal coronary angioplasty. A randomized study of a multifactorial programme. Eur Heart J (1999) 1.28
Haemorrhagic and thromboembolic complications in patients with atrial fibrillation on anticoagulant prophylaxis. J Intern Med (1989) 1.26
Binding of human extracellular superoxide dismutase C to sulphated glycosaminoglycans. Biochem J (1988) 1.26
Mode of death in heart failure: findings from the ATLAS trial. Heart (2003) 1.24
Improved physical fitness and quality of life following training of elderly patients after acute coronary events. A 1 year follow-up randomized controlled study. Eur Heart J (1999) 1.23
Recessive amyotrophic lateral sclerosis families with the D90A SOD1 mutation share a common founder: evidence for a linked protective factor. Hum Mol Genet (1998) 1.22
Quality-of-life in patients treated with atrioventricular synchronous pacing compared to rate modulated ventricular pacing: a long-term, double-blind, crossover study. Pacing Clin Electrophysiol (1992) 1.21
Binding of human extracellular-superoxide dismutase C to cultured cell lines and to blood cells. Lab Invest (1989) 1.21
Markers of high fish intake are associated with decreased risk of a first myocardial infarction. Br J Nutr (2001) 1.18
Plasma clearance of human extracellular-superoxide dismutase C in rabbits. J Clin Invest (1988) 1.18
Aortic valve replacement in octogenarians with aortic stenosis: a case-control study. J Am Coll Cardiol (1992) 1.18
Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arterioscler Thromb Vasc Biol (1998) 1.18
Physiological versus single-rate ventricular pacing: a double-blind cross-over study. Pacing Clin Electrophysiol (1985) 1.16
Joint efforts across national boundaries between professional organizations in cardiovascular medicine: one way into the future. J Am Coll Cardiol (2000) 1.15
Chronic atrial fibrillation. Long-term results of direct current conversion. Acta Med Scand (1988) 1.15
Single-chain structure of human ceruloplasmin. Eur J Biochem (1972) 1.14
Comparison of physical work capacity and systolic time intervals with ventricular inhibited and atrial synchronous ventricular inhibited pacing. Br Heart J (1981) 1.14
The effect of ventricular activation sequence on cardiac performance during pacing. Pacing Clin Electrophysiol (1996) 1.14
Interactions between human extracellular superoxide dismutase C and sulfated polysaccharides. J Biol Chem (1989) 1.13
Augmented metabolic control improves myocardial diastolic function and perfusion in patients with non-insulin dependent diabetes. Heart (2004) 1.12
Superoxide dismutase isoenzymes in the normal and diseased human cornea. Invest Ophthalmol Vis Sci (2001) 1.12
Management of atrial fibrillation: discrepancy between guideline recommendations and actual practice exposes patients to risk for complications. Eur Heart J (2001) 1.12
Molecular weight of beef heart aconitase and stoichiometry of the components of its iron-sulfur cluster. J Biol Chem (1984) 1.12
Isolation and properties of a staphylococcal protease, preferentially cleaving glutamoyl-peptide bonds. Eur J Biochem (1974) 1.12
Tocainide kinetics after intravenous and oral administration in healthy subjects and in patients with acute myocardial infarction. Clin Pharmacol Ther (1980) 1.10
Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues. Biochem J (1993) 1.10
Causes of more frequent deletions than insertions in mutations and protein evolution. Nature (1981) 1.10
Diabetes mellitus and congestive heart failure. Further knowledge needed. Eur Heart J (1999) 1.09
Long term experience of felodipine in combination with beta-blockade and diuretics in refractory hypertension. Drugs (1985) 1.08
Pathology parameters and adjuvant tamoxifen response in a randomised premenopausal breast cancer trial. J Clin Pathol (2005) 1.07
A double-blind trial of metoprolol in acute myocardial infarction. Effects on ventricular tachyarrhythmias. N Engl J Med (1983) 1.06
Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy. PIC Study Group. Pacing In Cardiomyopathy. Am J Cardiol (1999) 1.06
Differences in basal airway antioxidant concentrations are not predictive of individual responsiveness to ozone: a comparison of healthy and mild asthmatic subjects. Free Radic Biol Med (2001) 1.05
Sustained effect of hydralazine in long term treatment of CHF. Acta Med Scand Suppl (1981) 1.05
Results of atrioventricular synchronous pacing with optimized delay in patients with severe congestive heart failure. Am J Cardiol (1995) 1.04
Turnover of extracellular-superoxide dismutase in tissues. Lab Invest (1994) 1.03
Application of oxygen free radical scavengers to diminish the occurrence of myringosclerosis. Ann Otol Rhinol Laryngol (1997) 1.02
Non-enzymic glycation of human extracellular superoxide dismutase. Biochem J (1991) 1.02
Mercury, selenium, and glutathione peroxidase before and after amalgam removal in man. Acta Odontol Scand (1990) 1.01
Metoprolol and atenolol administered once daily in primary hypertension. A clinical comparison of the efficacy of two selective beta-adrenoceptor blocking agents. Acta Med Scand (1981) 1.01
The amino-acid sequences of three tryptic glycopeptides from human ceruloplasmin. Eur J Biochem (1974) 1.01
Effect of lignocaine on heart rate in patients with sinus bradycardia associated with proven or suspected acute myocardial infarction. Cardiovasc Res (1972) 1.01
The rat extracellular superoxide dismutase dimer is converted to a tetramer by the exchange of a single amino acid. Proc Natl Acad Sci U S A (1996) 1.00